- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Bristol-Myers Squibb Co
+ Add to WatchlistBMY:US
43.7600 USD 0.4600 1.06%As of 20:04:07 ET on 05/20/2013.
Company Profile for Bristol-Myers Squibb Co (BMY)
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Contact Information
Bristol-Myers Squibb Co
345 Park Avenue
New York, NY 10154-0037
United States
Key Executives for Bristol-Myers Squibb Co (BMY)
| Lamberto AndreottiChief Executive Officer | Francis CussChief Scientific Officer |
| Louis S SchmuklerPres:Global Manufacturing | Giovanni CaforioPres:US Pharmaceuticals |
| Charles A BancroftExec VP/CFO | Elliott SigalExec VP/Chief Scientific Ofcr |
| Beatrice J CazalaExec VP:Commercial Operations | Paul Von AutenriedSenior VP:Enterprise Svcs/CIO |
| Frances K HellerSenior VP:Business Development | Brian DanielsSenior VP:Global Development |
| Ann Powell JudgeSenior VP:Human Resources | John ElickerSenior VP:Investor Relations |
| Samuel J MoedSenior VP:Strategic Planning | Francis CussChief Scientific Officer |
| Sandra LeungSecretary/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page